https://www.selleckchem.com/pr....oducts/azd5153-6-hyd
se than younger patients based on validated GC scores. PATIENT SUMMARY The presented clinical-genomic data demonstrate that elderly patients with low-risk prostate cancer might harbor more aggressive disease than their younger counterparts. This suggests that standard well-accepted paradigm of elderly prostate cancer patients not being aggressively treated, based solely on their chronological age, might need to be reconsidered. INTRODUCTION Cigarette smoking remains more common among individuals with depressio